What is the recommended conservative outpatient treatment for acute colitis?

Conservative Outpatient Treatment for Acute Colitis

For mild to moderate ulcerative colitis managed as an outpatient, start with oral 5-ASA (mesalamine) 2-4.8 g/day combined with rectal 5-ASA 1 g daily, and escalate to oral prednisolone 40 mg daily if no response within 4-8 weeks. 1, 2

First-Line Therapy: 5-ASA (Aminosalicylates)

The cornerstone of outpatient management depends on disease extent:

For Proctitis (Rectal Disease Only)

• Rectal 5-ASA suppositories 1 g daily are the preferred initial treatment 1, 3
• Suppositories deliver medication more effectively to the rectum than foam or enemas and are better tolerated 3
• Rectal 5-ASA is superior to rectal corticosteroids for inducing remission (pooled OR 1.65) 1

For Left-Sided or Extensive Colitis

• Combination therapy is superior to monotherapy: Oral 5-ASA 2-4.8 g/day PLUS rectal 5-ASA enemas (at least 1 g daily) 1, 2
• The British Society of Gastroenterology strongly recommends this combination approach over oral treatment alone 2
• Once-daily dosing is as effective as divided doses and improves adherence 1

Response Assessment

• Evaluate for symptomatic response at 4-8 weeks 1
• If flaring on 5-ASA, escalate oral dose to 4-4.8 g/day alongside rectal therapy before moving to corticosteroids 2

Second-Line Therapy: Oral Corticosteroids

When 5-ASA fails or is not tolerated:

• Oral prednisolone 40 mg daily is the standard second-line treatment 2, 4
• Taper gradually over 6-8 weeks according to clinical response 2, 4
• Prednisolone is superior to 5-ASA for induction but has significant side effects, so reserve for 5-ASA failure 2

Alternative Topical Corticosteroids

For patients wishing to avoid systemic steroids:

• Budesonide MMX 9 mg daily (moderate evidence): Week 8 remission rate 17.7% vs 6.2% placebo, particularly effective for left-sided disease 2
• Beclomethasone dipropionate (weaker evidence) 2
• These have fewer systemic side effects than prednisolone

Critical Pitfalls to Avoid

Do not switch between different oral 5-ASA formulations if one fails—this is ineffective and wastes time 1. Instead, escalate to corticosteroids.

Do not use topical corticosteroids as first-line therapy—they are less effective than topical 5-ASA and should only be used if patients are intolerant of mesalamine 4

Do not delay escalation beyond 4-8 weeks of failed 5-ASA therapy, as prolonged active disease increases morbidity 1

When to Hospitalize

Patients requiring hospitalization (not outpatient management) meet Truelove and Witts' criteria for severe colitis:

• ≥6 bloody stools per day PLUS any of:
  • Heart rate >90 bpm
  • Temperature >37.8°C
  • Hemoglobin <10.5 g/dL
  • ESR >30 mm/h (or CRP >30 mg/L)

These patients require intravenous corticosteroids (hydrocortisone 100 mg four times daily or methylprednisolone 40-60 mg daily) and cannot be managed conservatively as outpatients 2, 3, 5.

Treatment Escalation Beyond Conservative Therapy

If patients require two or more courses of corticosteroids in the past year or become corticosteroid-dependent/refractory, they need treatment escalation to thiopurines, anti-TNF therapy, vedolizumab, or tofacitinib—this is beyond conservative outpatient management 2.

Maintenance After Remission

Once remission is achieved with oral/rectal 5-ASA:

• Continue the same therapy that induced remission 1
• Maintain at least 2 g/day oral 5-ASA for extensive disease 1
• Lifelong maintenance is recommended, especially for left-sided or extensive disease 4

Monitoring Requirements

For patients on long-term 5-ASA:

• Check renal function (including eGFR) before starting, at 2-3 months, then annually due to rare nephrotoxicity risk 2